Elevation of C-reactive protein and interleukin-6 in plasma of patients with aggressive periodontitis

Journal of Periodontal Research

Volumn 44, Issue 3, 2009, Pages 311-316

  Sun, X J ^a   Meng, H X ^a   Shi, D ^a   Xu, L ^a   Zhang, L ^a   Chen, Z B ^a   Feng, X H ^a   Lu, R F ^a   Ren, X Y ^a  

^a PEKING UNIVERSITY   (China)

Author keywords

Aggressive periodontitis; C reactive proteins; Interleukin 6

Indexed keywords

AUTACOID; C REACTIVE PROTEIN; INTERLEUKIN 6;

ADULT; ARTICLE; BLOOD; CASE CONTROL STUDY; CHINA; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; IMMUNOLOGY; MALE; PERIODONTITIS; STATISTICAL MODEL;

ADULT; AGGRESSIVE PERIODONTITIS; BLOOD GLUCOSE; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CHINA; FEMALE; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-6; LINEAR MODELS; MALE;

EID: 65349128164     PISSN: 00223484     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0765.2008.01131.x     Document Type: Article

References (36)

1. Ridker PM. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 2003 107 : 363 369. (Pubitemid 36158034)
2. Freeman DJ, Norrie J, Caslake MJ et al. C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study. Diabetes 2002 51 : 1596 1600.
3. Biasucci L, Vitelli A, Liuzzo G et al. Elevated levels of interleukin-6 in unstable angina. Circulation 1996 94 : 874 877. (Pubitemid 26292834)
4. Vozarova B, Weyer C, Hanson K, Tataranni PA, Bogardus C, Pratley RE. Circulating interleukin-6 in relation to adiposity, insulin action, and insulin secretion. Obes Res 2001 9 : 414 417. (Pubitemid 33603868)
5. Loos BG, Craandijik J, Hoek FJ, Wertheim-van Dillen ME, Van Der Velden U. Elevation of systemic markers related to cardiovascular diseases in the peripheral blood of periodontitis patients. J Periodontol 2000 71 : 1528 1534.
6. Yamazaki K, Honda T, Oda T et al. Effect of periodontal treatment on the C-reactive protein and proinflammatory cytokine levels in Japanese periodontitis patients. J Periodont Res 2005 40 : 53 58. (Pubitemid 40186627)
7. Noack B, Genco RJ, Trevisan M, Grossi S, Zambon JJ, De Nardin E. Periodontal infections contribute to elevated systemic C-reactive protein level. J Periodontology 2001 72 : 1221 1227. (Pubitemid 33607184)
8. Beck JD, Eke P, Heiss G et al. Periodontal disease and coronary heart disease: a reappraisal of the exposure. Circulation 2005a 112 : 19 24. (Pubitemid 40962564)
9. Taylor GW, Burt BA, Becker MP et al. Severe periodontitis and risk for poor glycemic control in patients with non-insulin-dependent diabetes mellitus. J Periodontol 1996 67 (Suppl. 10 1085 1093. (Pubitemid 126613089)
10. Salzberg TN, Overstreet BT, Rogers JD, Califano JV, Best AM, Schenkein HA. C-reactive protein levels in patients with aggressive periodontitis. J Periodontol 2006 77 : 933 939.
11. Shi D, Meng HX, Xu L, Zhang L, Chen ZB, Feng XH. Blood lipids and glucose levels in patients with periodontitis. Zhong Hua Kou Qiang Yi Xue 2007 41 : 401 402. (Pubitemid 350097042)
12. Sun XJ, Meng HX, Chen ZB et al. Levels of interleukin-1β and Tumor necrosis factor-α in patients with Aggressive periodontitis. Beijing Da Xue Xue Bao 2008 40 : 24 27.
13. Hutchinson WL, Koenig W, Frohlich M et al. Immunoradiometric assay of circulating C-reactive protein: age-related values in the adult general population. Clin Chem 2000 46 : 934 938. (Pubitemid 30461263)
14. Ershler WB, Sun WH, Binkley N et al. Interleukin-6 and aging: blood levels and mononuclear cell production increase with advancing age and in vitro production is modifiable by dietary restriction. Lymphokine Cytokine Res 1993 12 : 225 230. (Pubitemid 23264834)
15. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004 27 : 1047 1053. (Pubitemid 38579764)
16. Torpy JM, Lynm C, Glass RM. Risk factors for heart disease. JAMA 2003 290 : 980. (Pubitemid 37430471)
17. Danesh J, Collins R, Appleby P, Peto R. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. JAMA 1998 279 : 1477 1482. (Pubitemid 28228207)
18. Fredriksson M, Figueredo C, Gustafsson A, Bergström K, Åsman B. Effect of periodontitis and smoking on blood leukocytes and acute-phase proteins. J Periodontol 1999 70 : 1355 1360.
19. Güntsch A, Erler M, Preshaw PM, Sigusch BW, Klinger G, Glockmann E. Effect of smoking on crevicular polymorphonuclear neutrophil function in periodontally healthy subjects. J Periodontal Res 2006 41 : 184 188.
20. Khera A, McGuire DK, Murphy SA et al. Race and gender differences in C-reactive protein levels. J Am Coll Cardiol 2005 46 : 464 469. (Pubitemid 41040287)
21. Albert MA, Glynn RJ, Buring J, Ridker PM. C-reactive protein levels among women of various ethnic groups living in the United States (from the Women's Health Study). Am J Cardiol 2004 93 : 1238 1242. (Pubitemid 38595677)
22. Yamada S, Gotoh T, Nakashima Y et al. Distribution of serum C-reactive protein and its association with atherosclerotic risk factors in a Japanese population: Jichi Medical School Cohort Study. Am J Epidemiol 2001 153 : 1183 1190. (Pubitemid 32552276)
23. Pitiphat W, Savetsilp W, Wara-Aswapati N. C-reactive protein associated with periodontitis in a Thai population. J Clin Periodontol 2008 35 : 120 125. (Pubitemid 352847598)
24. Gabay C, Kushner I. Acute-phase proteins and other systemic response to inflammation. N Engl J Med 1999 340 : 48 454. (Pubitemid 29084777)
25. Torzewski M, Rist C, Mortensen RF et al. C-reactive protein in the arterial intima: role of C-reactive protein receptor-dependent monocyte recruitment in atherogenesis. Arterioscler Thromb Vasc Biol 2000 20 : 2094 2099. (Pubitemid 30479470)
26. Du Clos TW. Function of C-reactive protein. Ann Med 2000 32 : 274 278. (Pubitemid 30311864)
27. Steel DM, Whitehead AS. The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein. Immunol Today 1994 15 : 81 88. (Pubitemid 24049801)
28. Maseri A, Biasucci LM, Liuzzo G. Inflammation in ischaemic heart disease. BMJ 1996 312 : 1049 1050. (Pubitemid 26125125)
29. Al-Khalili L, Bouzakri K, Glund S, Lönnqvist F, Koistinen HA, Krook A. Signalling specificity of interleukin-6 action on glucose and lipid metabolism in skeletal muscle. Mol Endocrinol 2006 20 : 3364 3375.
30. Bastard JP, Maachi M, van Nhieu JT et al. Adipose tissue IL-6 content correlates with resistance to insulin activation of glucose uptake both in vivo and in vitro. J Clin Endocrinol Metab 2002 87 : 2084 2089. (Pubitemid 34521492)
31. Spranger J, Kroke A, Mohlig M et al. Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European prospective investigation into cancer and nutrition (EPIC)-Potsdam study. Diabetes 2003 52 : 812 817. (Pubitemid 36323590)
32. Tsigos C, Papanicolaou DA, Kyrou I, Defensor R, Mitsiadis CS, Chrousos GP. Dose-dependent effects of recombinant human interleukin-6 on glucose regulation. J Clin Endocrinol Metab 1997 82 : 4167 4170. (Pubitemid 27525533)
33. Klover PJ, Zimmers TA, Koniaris LG, Mooney RA. Chronic exposure to interleukin 6 causes hepatic insulin resistance in mice. Diabetes 2003 52 : 2784 2789. (Pubitemid 37339708)
34. Senn JJ, Klover PJ, Nowak IA, Mooney RA. Interleukin-6 induces cellular insulin resistance in hepatocytes. Diabetes 2002 51 : 3391 3399. (Pubitemid 35403441)
35. Taniguchi CM, Emanuelli B, Kahn CR. Critical nodes in signalling pathways: insights into insulin action. Nat Rev Mol Cell Biol 2006 7 : 85 96. (Pubitemid 43278292)
36. Glund S, Zierath JR. Tackling the insulin-signalling cascade. Can J Diabetes 2005 29 : 239 245. (Pubitemid 43741140)